Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment

Lung cancer is the leading cause of death from cancer worldwide. Recent studies demonstrated that the tumour microenvironment (TME) is pivotal for tumour progression, providing multiple targeting opportunities for therapeutic strategies. As one of the most abundant stromal cell types in the TME, tum...

Full description

Bibliographic Details
Main Authors: Xiang Zheng, Siavash Mansouri, Annika Krager, Friedrich Grimminger, Werner Seeger, Soni S. Pullamsetti, Craig E. Wheelock, Rajkumar Savai
Format: Article
Language:English
Published: European Respiratory Society 2020-10-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/29/157/200134.full
_version_ 1818523113254551552
author Xiang Zheng
Siavash Mansouri
Annika Krager
Friedrich Grimminger
Werner Seeger
Soni S. Pullamsetti
Craig E. Wheelock
Rajkumar Savai
author_facet Xiang Zheng
Siavash Mansouri
Annika Krager
Friedrich Grimminger
Werner Seeger
Soni S. Pullamsetti
Craig E. Wheelock
Rajkumar Savai
author_sort Xiang Zheng
collection DOAJ
description Lung cancer is the leading cause of death from cancer worldwide. Recent studies demonstrated that the tumour microenvironment (TME) is pivotal for tumour progression, providing multiple targeting opportunities for therapeutic strategies. As one of the most abundant stromal cell types in the TME, tumour-associated macrophages (TAMs) exhibit high plasticity. Malignant cells alter their metabolic profiles to adapt to the limited availability of oxygen and nutrients in the TME, resulting in functional alteration of TAMs. The metabolic features of TAMs are strongly associated with their functional plasticity, which further impacts metabolic profiling in the TME and contributes to tumourigenesis and progression. Here, we review the functional determination of the TME by TAM metabolic alterations, including glycolysis as well as fatty acid and amino acid metabolism, which in turn are influenced by environmental changes. Additionally, we discuss metabolic reprogramming of TAMs to a tumouricidal phenotype as a potential antitumoural therapeutic strategy.
first_indexed 2024-12-11T05:41:12Z
format Article
id doaj.art-03b5a88b24494b4999b2aad5db14a5e3
institution Directory Open Access Journal
issn 0905-9180
1600-0617
language English
last_indexed 2024-12-11T05:41:12Z
publishDate 2020-10-01
publisher European Respiratory Society
record_format Article
series European Respiratory Review
spelling doaj.art-03b5a88b24494b4999b2aad5db14a5e32022-12-22T01:19:07ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172020-10-012915710.1183/16000617.0134-20200134-2020Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironmentXiang Zheng0Siavash Mansouri1Annika Krager2Friedrich Grimminger3Werner Seeger4Soni S. Pullamsetti5Craig E. Wheelock6Rajkumar Savai7 Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim, Germany Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim, Germany Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim, Germany Dept of Internal Medicine, Member of the DZL, Member of CPI, Justus Liebig University, Giessen, Germany Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim, Germany Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim, Germany Division of Physiological Chemistry 2, Dept of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad Nauheim, Germany Lung cancer is the leading cause of death from cancer worldwide. Recent studies demonstrated that the tumour microenvironment (TME) is pivotal for tumour progression, providing multiple targeting opportunities for therapeutic strategies. As one of the most abundant stromal cell types in the TME, tumour-associated macrophages (TAMs) exhibit high plasticity. Malignant cells alter their metabolic profiles to adapt to the limited availability of oxygen and nutrients in the TME, resulting in functional alteration of TAMs. The metabolic features of TAMs are strongly associated with their functional plasticity, which further impacts metabolic profiling in the TME and contributes to tumourigenesis and progression. Here, we review the functional determination of the TME by TAM metabolic alterations, including glycolysis as well as fatty acid and amino acid metabolism, which in turn are influenced by environmental changes. Additionally, we discuss metabolic reprogramming of TAMs to a tumouricidal phenotype as a potential antitumoural therapeutic strategy.http://err.ersjournals.com/content/29/157/200134.full
spellingShingle Xiang Zheng
Siavash Mansouri
Annika Krager
Friedrich Grimminger
Werner Seeger
Soni S. Pullamsetti
Craig E. Wheelock
Rajkumar Savai
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
European Respiratory Review
title Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
title_full Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
title_fullStr Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
title_full_unstemmed Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
title_short Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
title_sort metabolism in tumour associated macrophages a quid pro quo with the tumour microenvironment
url http://err.ersjournals.com/content/29/157/200134.full
work_keys_str_mv AT xiangzheng metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment
AT siavashmansouri metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment
AT annikakrager metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment
AT friedrichgrimminger metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment
AT wernerseeger metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment
AT sonispullamsetti metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment
AT craigewheelock metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment
AT rajkumarsavai metabolismintumourassociatedmacrophagesaquidproquowiththetumourmicroenvironment